Skip to main content
Fig. 1 | Skeletal Muscle

Fig. 1

From: CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Fig. 1

Higher relative numbers of CD49dhi T cells correlate with rapid disease progression. a CD49d membrane expression in CD4+ and CD8+ T cell subsets. The values correspond to the percentages of the T cell subpopulation with a high CD49d expression (CD49dhi T). Dashed bars define high versus low CD49d expression, and the red curves represent isotype-matched antibody. b Relative numbers of CD49dhiCD4+ and CD49dhiCD8+ T cells in different groups of DMD patients organized according to their disease progression, as well as healthy controls. c Retrospective study of wheelchair-bound patients organized according to the age when they lost ability to walk. d Prospective study in patients able to walk 1 m/s or less, organized according to the age when they became wheelchair bound. The number of DMD patients analyzed in each group appears in parentheses. b *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page